FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
DRI Cocaine Metabolite Assay
K Number: K211973
·
Decision Sep 24, 2021
Classifications
1
FEI Numbers
97
Registration Numbers
97
Same Product Code
144
Applicant Total
21
Review Days
91
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- DRI Cocaine Metabolite Assay
- K Number
- K211973
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 862.3250
- Medical Specialty
- Clinical Toxicology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Microgenics Corporation
- Date Received
- June 25, 2021
- Decision Date
- September 24, 2021
- Product Code
- DIO
- Advisory Committee
- Clinical Toxicology
- Review Advisory Committee
- TX
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| DIO | Enzyme Immunoassay, Cocaine And Cocaine Metabolites | FDA class 2 | Clinical Toxicology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (DIO), ordered by most recent decision date.
Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Enzyme Immunoassay (COCM) Test System
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Pointe Scientific Cocaine Metabolite Enzyme Immunoassay
FDA 510(k)
FDA Class 2
·Clinical Toxicology
DRI Cocaine Metabolite Assay
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Emit II Plus Cocaine Metabolite Assay
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Test System (COCM)
FDA 510(k)
FDA Class 2
·Clinical Toxicology
MP DOA-10 Panel Test Cup, MP DOA-11 Panel Test Cup
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Other Clearances by Microgenics Corporation
| K Number | Device Name | ||
|---|---|---|---|
| K243498 | Alinity c Benzodiazepines Reagent Kit | Dec 11, 2024 | Substantially Equivalent |
| K240670 | DRI Ecstasy Plus Assay | Oct 30, 2024 | Substantially Equivalent |
| K231020 | Alinity c Tricyclic Antidepressants Reagent Kit | Nov 17, 2023 | Substantially Equivalent |
| K231007 | CEDIA Heroin Metabolite (6-AM) Assay | Sep 27, 2023 | Substantially Equivalent |
| K213875 | DRI TM Tricyclics Serum Tox Assay | Dec 21, 2022 | Substantially Equivalent |
| K192943 | CEDIA Heroin Metabolite (6-AM) assay | Dec 16, 2019 | Substantially Equivalent |
| K190968 | CEDIA Benzodiazepine Assay | Dec 9, 2019 | Substantially Equivalent |
| DEN180030 | QMS Plazomicin Immunoassay | Nov 19, 2018 | Unknown |
| K181499 | DRI Cocaine Metabolite Assay | Jul 6, 2018 | Substantially Equivalent |
| K173963 | DRI Benzodiazepine Assay | Feb 21, 2018 | Substantially Equivalent |